# Nebulized Sub-dissociative Dose Ketamine for Treating Pain

> **NCT03909607** · PHASE4 · COMPLETED · sponsor: **Antonios Likourezos** · enrollment: 120 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Ketamine 0.75 mg/kg
- **DRUG:** Ketamine 1.0 mg/kg
- **DRUG:** Ketamine 1.5 mg/kg

## Key facts

- **NCT ID:** NCT03909607
- **Lead sponsor:** Antonios Likourezos
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-16
- **Primary completion:** 2020-10-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909607, "Nebulized Sub-dissociative Dose Ketamine for Treating Pain". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03909607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*